Filing Details
- Accession Number:
- 0001628280-24-025886
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-30 17:41:25
- Reporting Period:
- 2024-05-28
- Accepted Time:
- 2024-05-30 17:41:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604019 | Sara Bonstein | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-28 | 3,454 | $28.88 | 120,935 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-29 | 76,731 | $28.88 | 197,666 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 3,454 | $24.70 | 201,120 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-29 | 27,074 | $24.70 | 228,194 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 3,454 | $34.03 | 231,648 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-29 | 25,046 | $34.03 | 256,694 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 3,454 | $26.46 | 260,148 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-29 | 39,446 | $26.46 | 299,594 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 3,454 | $26.43 | 303,048 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-29 | 20,111 | $26.43 | 323,159 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 3,454 | $17.07 | 326,613 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-29 | 32,156 | $17.07 | 358,769 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-28 | 20,724 | $50.01 | 338,045 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-29 | 220,564 | $50.00 | 117,481 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,454 | $0.00 | 3,454 | $28.88 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-29 | 76,731 | $0.00 | 76,731 | $28.88 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,454 | $0.00 | 3,454 | $24.70 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-29 | 27,074 | $0.00 | 27,074 | $24.70 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,454 | $0.00 | 3,454 | $34.03 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-29 | 25,046 | $0.00 | 25,046 | $34.03 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,454 | $0.00 | 3,454 | $26.46 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-29 | 39,446 | $0.00 | 39,446 | $26.46 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,454 | $0.00 | 3,454 | $26.43 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-29 | 20,111 | $0.00 | 20,111 | $26.43 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,454 | $0.00 | 3,454 | $17.07 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-29 | 32,156 | $0.00 | 32,156 | $17.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 88,186 | 2030-02-03 | No | 4 | M | Direct | |
| 11,455 | 2030-02-03 | No | 4 | M | Direct | |
| 31,436 | 2030-05-12 | No | 4 | M | Direct | |
| 4,362 | 2030-05-12 | No | 4 | M | Direct | |
| 42,146 | 2031-01-07 | No | 4 | M | Direct | |
| 17,100 | 2031-01-07 | No | 4 | M | Direct | |
| 65,186 | 2031-05-12 | No | 4 | M | Direct | |
| 25,740 | 2031-05-12 | No | 4 | M | Direct | |
| 59,386 | 2032-01-06 | No | 4 | M | Direct | |
| 39,275 | 2032-01-06 | No | 4 | M | Direct | |
| 91,506 | 2032-05-11 | No | 4 | M | Direct | |
| 59,350 | 2032-05-11 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 20,724 shares sold at prices ranging from $50.00 to $50.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 220,564 shares sold at prices ranging from $50.00 to $50.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
- The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date.
Billionaire Hedge Funds
